Lack of access to COVID-19 vaccines for people in the world’s poorest countries echoes the health inequity faced by people affected by TB.

A communities report on progress towards the UN Political Declaration on the Fight Against TB and a Call to Action to close the gaps in TB targets

The report — Tuberculosis Research Funding Trends, 2005–2019 — presents new data on 2019 funding for TB research and development and analyzes trends in investment since 2005.

EGPAF, WHO, PEPFAR, UNAIDS, Stop TB Partnership and FBOs: World Children’s Day statement on advances in access to paediatric HIV and TB diagnosis and treatments

Treatment Action Group (TAG) launches newly available TB chapters of its 2020 Pipeline Report.

Data on 37 countries reveals widespread failure to follow latest international recommendations for policies on prevention, diagnosis, and treatment.

Smart medication container included in Stop TB Partnership's Global Drug Facility (GDF) product catalog.

TB treatment can be shortened from six to four months in 80% of children.

Landmark phase III trial shows that the shorter regimen containing rifapentine and moxifloxacin can safely and effectively cure TB in four months.

UN Secretary-General outlines priority recommendations to accelerate the TB response and reach targets.